Investor
Illumina
Foster City · United States
Independently managed venture firm focused on early-stage genomics and precision health companies to improve human health and transform healthcare.
Stage
Seed–Series A
Sectors
Not confirmed
Cheque
Not confirmed
Invests in
Global
About
This firm focuses on the genomics and precision health ecosystem. It supports early-stage companies to improve human health through depth of knowledge and domain expertise. Through its labs, it provides early-stage genomics start-ups with access to capital, sequencing, and mentorship. It operates as a partner to entrepreneurs developing breakthrough science and technology.
Portfolio · 5 · tap a company to read about it
Recent deals
- 2025-11HeptaSeedLed
- 2025-11HeptaSeed
- 2023-10Actym TherapeuticsSeries A
- 2023-10Actym TherapeuticsSeries A
- 2022-12SonoThera™Series A
- 2022-12SonoThera™Series A
- 2022-03Sherlock BiosciencesSeries B
- 2021-11Arbor BiotechnologiesSeries B
- 2021-11Arbor BiotechnologiesSeries B
- 2020-11Rebus Biosystems, Inc.Series BLed
- 2020-11Rebus Biosystems, Inc.Series B
